LU85974A1 - Melange de gangliosides utile comme instrument therapeutique d'elimination d'effets douloureux de neuropathies peripheriques - Google Patents

Melange de gangliosides utile comme instrument therapeutique d'elimination d'effets douloureux de neuropathies peripheriques Download PDF

Info

Publication number
LU85974A1
LU85974A1 LU85974A LU85974A LU85974A1 LU 85974 A1 LU85974 A1 LU 85974A1 LU 85974 A LU85974 A LU 85974A LU 85974 A LU85974 A LU 85974A LU 85974 A1 LU85974 A1 LU 85974A1
Authority
LU
Luxembourg
Prior art keywords
gangliosides
approximately
ganglioside
composition
pain
Prior art date
Application number
LU85974A
Other languages
English (en)
French (fr)
Inventor
Aurelio Romeo
Francesco Della Valle
Silvana Lorenzi
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of LU85974A1 publication Critical patent/LU85974A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU85974A 1984-07-03 1985-06-26 Melange de gangliosides utile comme instrument therapeutique d'elimination d'effets douloureux de neuropathies peripheriques LU85974A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4849184 1984-07-03
IT48491/84A IT1177863B (it) 1984-07-03 1984-07-03 Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche

Publications (1)

Publication Number Publication Date
LU85974A1 true LU85974A1 (fr) 1986-01-22

Family

ID=11266882

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85974A LU85974A1 (fr) 1984-07-03 1985-06-26 Melange de gangliosides utile comme instrument therapeutique d'elimination d'effets douloureux de neuropathies peripheriques

Country Status (11)

Country Link
US (1) US4707469A (de)
EP (1) EP0183572B1 (de)
JP (1) JPS6130521A (de)
AT (1) ATE78171T1 (de)
AU (1) AU582757B2 (de)
BE (1) BE902753A (de)
DE (1) DE3523021A1 (de)
GR (1) GR851572B (de)
IT (1) IT1177863B (de)
LU (1) LU85974A1 (de)
ZA (1) ZA854865B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111407768A (zh) * 2020-05-15 2020-07-14 内蒙古自治区中医药研究所 一类组合物在神经损伤保护领域的应用

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6168418A (ja) * 1984-09-11 1986-04-08 Kanto Ishi Pharma Co Ltd 去痰薬
EP0267297B1 (de) * 1986-05-12 1993-09-15 Mect Corporation Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IN171530B (de) * 1989-11-17 1992-11-07 Fidia Spa
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
JPH05508396A (ja) * 1991-05-16 1993-11-25 フィディーア・ソシエタ・ペル・アチオニ 非従来型ウイルスによる汚染を含有しないグリコスフィンゴ脂質混合物の生産及び精製方法
EP1349567A4 (de) * 2000-12-08 2005-10-12 Childrens Memorial Hospital Zusammensetzungen mit gangliosiden zur verwendung bei der behandlung von hauterkrankungen
AU2002326805B2 (en) 2001-08-29 2009-01-22 Seneb Biosciences, Inc. Novel synthetic ganglioside derivatives and compositions thereof
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
WO2004080960A2 (en) 2003-03-06 2004-09-23 Neose Technologies Inc. Methods and compositions for the enzymatic synthesis of gangliosides
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1046051B (it) * 1975-08-13 1980-06-30 Fidia Spa Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111407768A (zh) * 2020-05-15 2020-07-14 内蒙古自治区中医药研究所 一类组合物在神经损伤保护领域的应用

Also Published As

Publication number Publication date
IT8448491A1 (it) 1986-01-03
EP0183572A2 (de) 1986-06-04
AU582757B2 (en) 1989-04-13
BE902753A (nl) 1985-12-30
ZA854865B (en) 1987-09-30
EP0183572A3 (en) 1987-07-22
EP0183572B1 (de) 1992-07-15
DE3523021A1 (de) 1986-01-09
GR851572B (de) 1985-11-25
IT1177863B (it) 1987-08-26
ATE78171T1 (de) 1992-08-15
IT8448491A0 (it) 1984-07-03
US4707469A (en) 1987-11-17
JPS6130521A (ja) 1986-02-12
AU4420785A (en) 1986-01-02

Similar Documents

Publication Publication Date Title
LU85974A1 (fr) Melange de gangliosides utile comme instrument therapeutique d'elimination d'effets douloureux de neuropathies peripheriques
JP5561700B2 (ja) 新規糖脂質及びその用途
EP1464330B1 (de) Antiallergische Zusammensetzung, die OLIGOSACCHARIDe und eine Saponine oder eine basische Aminosäure enthält, zur topischen Verabreichung oder Inhalation
EP2563370B1 (de) Verwendung einer phospholipid und glycyrrhizinsäure enthaltenden zusammensetzung zur entfernung von subkutanen fettansammlungen durch subkutane lipolyse
JP5640019B2 (ja) 糖尿病及び肥満症を治療するためのプテロシン化合物の使用
LU85973A1 (fr) Utilisation therapeutique de gm1 dans des pathologies cerebrales severes dues a une ischemie
DE69218222T2 (de) Neue ganglioside-derivaten
US5190925A (en) Use of gangliosides in the treatment of autonomic dysfunction in Chagas' disease
HUT58206A (en) Process for utilizing gm1-monosilano-gangliozide and inner esters for inhibiting habit to morphine and analogues in human patients
EP0251298B1 (de) Anwendung exogener Ganglioside zur Herstellung eines Arzneimittels zur Anwendung bei Tumorkrankheiten als Schutzmittel gegen die Toxizität tumorhemmender Arzneimittel
JP4643009B2 (ja) 癌治療のための新規化合物
US20030143282A1 (en) Adenosine A3 receptor agonist
US9956196B2 (en) Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
KR100892764B1 (ko) 폐암 치료용 진세노사이드 조성물
KR100485936B1 (ko) 진세노사이드 Rh2 및 Rg3 항암 조성물
CN1651395B (zh) 冰片脂肪酸酯衍生物及含有该衍生物的制剂
JP2005187341A (ja) プロスタグランジンｅ２産生抑制剤及び抗炎症剤
EP0401426B1 (de) Verwendung von Gangliosiden zur Behandlung der Dysfunktion des autonomen Nervensystems bei der Chagas-Krankheit
WO2001055083A1 (en) Inositol derivatives and their pharmaceutical use
JPWO2018225728A1 (ja) グリコサミノグリカン産生促進剤及びグリコサミノグリカン産生促進用組成物
TW200922605A (en) Composition and treatment
JPH0794388B2 (ja) 乾癬治療剤

Legal Events

Date Code Title Description
DT Application date
TA Annual fee